Literature DB >> 7576713

Analysis of respiratory mucus glycoproteins in asthma: a detailed study from a patient who died in status asthmaticus.

J K Sheehan1, P S Richardson, D C Fung, M Howard, D J Thornton.   

Abstract

Airway mucus from asthmatics is often unusually solid. The death of a patient in status asthmaticus allowed the collection of 28 g of abnormal airway mucus at autopsy. Its chemical and physical properties were studied to reveal differences from more normal airway mucus. The gel plug taken from the airways could be dispersed in 6 M guanidinium chloride, but it took > 1 wk and 700 ml of extractant to disperse 3 g of exudate completely. In contrast, treatment with 10 mM dithiothreitol, which reduces disulfide bonds, dispersed the gel within seconds. Mucins accounted for 25% of the non-dialyzable material in the gel, while DNA constituted < 1% and proteoglycans could not be detected. The mucins were similar in architecture and general composition to other respiratory mucins and were present at a high concentration (approximately 40 mg/ml). The majority of mucins were of extreme size (mean M(r) 30-40 x 10(6)) and slow to dissolve, but sequential extraction experiments on the gel exudate demonstrated a proportion of mucins (15%), the most readily extracted, which had a higher density, 1.45-1.55 g/ml, a lower M(r) (11.5 x 10(6)) and were markedly more acidic than the bulk of the mucins. Both major and minor mucin populations were extremely heterogeneous in mass distribution. Electron microscopy of the major mucin species demonstrated extensive networks of molecules many microns in length. The major mucin species was distinctly less acidic than mucins previously described from either normal or diseased airways. Amino acid analysis of fractions across the charge distribution suggested the presence of at least two different mucin proteins occurring as distinct glycoforms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7576713     DOI: 10.1165/ajrcmb.13.6.7576713

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  32 in total

1.  Physical characterization of a low-charge glycoform of the MUC5B mucin comprising the gel-phase of an asthmatic respiratory mucous plug.

Authors:  J K Sheehan; M Howard; P S Richardson; T Longwill; D J Thornton
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

Review 2.  Airway mucus: From production to secretion.

Authors:  Olatunji W Williams; Amir Sharafkhaneh; Victor Kim; Burton F Dickey; Christopher M Evans
Journal:  Am J Respir Cell Mol Biol       Date:  2006-01-13       Impact factor: 6.914

Review 3.  Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways.

Authors:  Christopher M Evans; Tasha E Fingerlin; Marvin I Schwarz; David Lynch; Jonathan Kurche; Laura Warg; Ivana V Yang; David A Schwartz
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

Review 4.  Airway mucus function and dysfunction.

Authors:  John V Fahy; Burton F Dickey
Journal:  N Engl J Med       Date:  2010-12-02       Impact factor: 91.245

Review 5.  The therapeutic potential of CFTR modulators for COPD and other airway diseases.

Authors:  George M Solomon; Lianwu Fu; Steven M Rowe; James F Collawn
Journal:  Curr Opin Pharmacol       Date:  2017-11-10       Impact factor: 5.547

6.  Identification of trans Protein QTL for Secreted Airway Mucins in Mice and a Causal Role for Bpifb1.

Authors:  Lauren J Donoghue; Alessandra Livraghi-Butrico; Kathryn M McFadden; Joseph M Thomas; Gang Chen; Barbara R Grubb; Wanda K O'Neal; Richard C Boucher; Samir N P Kelada
Journal:  Genetics       Date:  2017-08-29       Impact factor: 4.562

7.  Epithelial tethering of MUC5AC-rich mucus impairs mucociliary transport in asthma.

Authors:  Luke R Bonser; Lorna Zlock; Walter Finkbeiner; David J Erle
Journal:  J Clin Invest       Date:  2016-05-16       Impact factor: 14.808

8.  Characterization of novel beta-galactosidase activity that contributes to glycoprotein degradation and virulence in Streptococcus pneumoniae.

Authors:  Vanessa S Terra; Karen A Homer; Susmitha G Rao; Peter W Andrew; Hasan Yesilkaya
Journal:  Infect Immun       Date:  2009-10-19       Impact factor: 3.441

9.  Ex vivo sputum analysis reveals impairment of protease-dependent mucus degradation by plasma proteins in acute asthma.

Authors:  Anh L Innes; Stephen D Carrington; David J Thornton; Sara Kirkham; Karine Rousseau; Ryan H Dougherty; Wilfred W Raymond; George H Caughey; Susan J Muller; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2009-05-07       Impact factor: 21.405

10.  Pyruvate formate lyase is required for pneumococcal fermentative metabolism and virulence.

Authors:  Hasan Yesilkaya; Francesca Spissu; Sandra M Carvalho; Vanessa S Terra; Karen A Homer; Rachel Benisty; Nurith Porat; Ana R Neves; Peter W Andrew
Journal:  Infect Immun       Date:  2009-09-14       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.